Hepatic Decompensation Hepatitis C Virus and HIV | Medical Algorithm

Evaluation

Are you evaluating a patient who is coinfected with HIV and HCV?

Yes

Is the patient being treated with ribavirin-interferon?

Yes

Is the patient being treated with didanosine?

Yes

Does the patient have cirrhosis?

Yes

Serum total bilirubin

Upper limit of the normal reference range for serum total bilirubin

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for hepatic decompensation

The risk of hepatic decompensation for this patient is

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Therapy

Pharmacogenetics
Dosage Calculations
Dosage Adjustments
- Chronic Viral Hepatitis C | Adjusting Dose of Copegus (Ribavirin)
- Chronic Viral Hepatitis C | Adjusting Dose of Interferon alfa-2b
Failure Handling And Therapy Escalation
- Primary Nonresponsiveness to Hepatitis B Virus Vaccine
Prevention

Monitoring

Response To Therapy
- Primary Nonresponsiveness to Hepatitis B Virus Vaccine
Compliance/adherence
- Vaccination Against Viral Hepatitis A & B in Patient with Chronic Liver Disease (CLD)

Societal Concerns

Public Health
- Vaccination Against Viral Hepatitis A & B in Patient with Chronic Liver Disease (CLD)

Specialty

Infectious Diseases
Pharmacology, clinical
Gastroenterology

Objective

risk factors
pharmacogenetics
adverse effects

ICD-10

B17.1 - Acute hepatitis C
B18.2 - Chronic viral hepatitis C

Hepatitis C Virus and HIV | Risk Factors for Hepatic Decompensation During Interferon-Ribavirin Therapy

Purpose: To identify risk factors for hepatic decompensation in a patient coinfected with HIV and HCV who is being treated with interferon-ribavirin.